Why Asia is the Emerging Epicenter for Global Biopharmaceutical Progress episode artwork

EPISODE · Mar 4, 2026 · 40 MIN

Why Asia is the Emerging Epicenter for Global Biopharmaceutical Progress

from The Bio Report · host Levine Media Group

Asia is quickly becoming a powerhouse for biopharma innovation, changing ideas about where breakthrough science and fast, cost-efficient drug development happen. A new McKinsey & Company report shows how countries like China, Japan, and India are each building their own strengths across the drug development continuum. We spoke to Fangning Zhang, a partner in McKinsey’s Shanghai office, about what’s driving this shift, how it could make innovation more affordable, and why treating Asia as optional may mean missing the next wave of global R&D.

NOW PLAYING

Why Asia is the Emerging Epicenter for Global Biopharmaceutical Progress

0:00 40:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bio Report?

This episode is 40 minutes long.

When was this The Bio Report episode published?

This episode was published on March 4, 2026.

What is this episode about?

Asia is quickly becoming a powerhouse for biopharma innovation, changing ideas about where breakthrough science and fast, cost-efficient drug development happen. A new McKinsey & Company report shows how countries like China, Japan, and India are...

Can I download this The Bio Report episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!